The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisitions is seeking proposals from Proteomic Center contractors to develop and enhance proteomic technologies and utilize them to gain a greater understanding of physiological pathways, molecular interactions, and regulatory signals. The contractors would also begin to apply the technologies and knowledge to clinical questions.
This announcement may be of interest to sleep/circadian researchers who can collaborate with proteomic programs/researchers in their region to incorporate biological timing and/or sleep apnea as part of an overall proposal. Since apnea is a common CVD co-morbidity, the incorporation of sleep/circadian phenotypes could potentially contribute to proposed scientific goals.
For more information contact the NHLBI.